Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Simon: Murine antithymocyte globulin therapy alters disease progression in NOD mice by a.... (0.12 sec) 

Human regulatory T cells: role in autoimmune disease and therapeutic …


T Brusko, A Putnam, J Bluestone - Immunological Reviews, 2008 - interscience.wiley.com
SummaryThe importance of regulatory T lymphocytes (Tregs) in the control of autoimmunity is now well
established in a variety of experimental animal models. In addition, there are numerous studies
suggesting that Treg deficits may ...
Cited by 31 - Related articles - All 4 versions

Clinical application of regulatory T cells for treatment of type 1 diabetes and …


T Brusko, J Bluestone - European Journal of Immunology, 2008 - interscience.wiley.com
Immune regulation is a complex process that depends on the maintenance of self tolerance while
retaining robust immune responses against microbes. The emergence of Treg as a central mechanism for
immune regulation has generated a ...
Cited by 10 - Related articles - BL Direct - All 2 versions

Immunotherapy of type 1 diabetes


L Li, Z Yi, R Tisch, B Wang - Archivum Immunologiae et Therapiae …, 2008 - Springer
Type 1 diabetes (T1D) is an autoimmune disease in which the insulin-producing β cells are
destroyed. Diabetic patients man- age their hyperglycemia by daily insulin injections. However,
insulin therapy is by no means a ...
Cited by 3 - Related articles - All 4 versions

Parameters influencing antigen-specific immunotherapy for type 1 diabetes


B Wang, R Tisch - Immunologic research, 2008 - Springer
Abstract Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease in which the insulin
producing b cells are destroyed. Antigen-based immunotherapy provides an approach to selectively
tolerize pathogenic b cell-specific ...
Cited by 1 - Related articles - All 4 versions

Rabbit Polyclonal Mouse Antithymocyte Globulin Administration Alters Dendritic …


Y Huang, M Parker, C Xia, R Peng, C … - The Journal of …, 2009 - Am Assoc Immnol
Mouse antithymocyte globulin (mATG) prevents, as well as reverses, type 1 diabetes in NOD mice,
through mechanisms involving modulation of the immunoregulatory activities of T lymphocytes.
Dendritic cells (DC) play a pivotal ...
Related articles - All 2 versions

[CITATION] In a mouse model thymoglobulin treatment results in depletion of naive as well as …


A Sener, AL Tang, DL Farber - American Journal of …, 2009 - Blackwell Publishing Inc
Related articles

[PDF] Immune Depletion with Cellular Mobilization Imparts Immunoregulation and …


MJ Parker, S Xue, JJ Alexander, CH Wasserfall, ML … - Diabetes, 2009 - diabetes.ufl.edu
Page 1. ATG + G-CSF Reverses Overt Diabetes in NOD Mice Immune Depletion with Cellular
Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in NOD Mice Running
Title: ATG + G-CSF Reverses Overt Diabetes in NOD Mice Matthew ...
Related articles - View as HTML - All 4 versions

In Vivo Characterization of Rabbit Anti-Mouse Thymocyte Globulin: A Surrogate for …


MC Ruzek, KS Neff, M Luong, KA Smith, K Culm- … - Transplantation, 2009 - journals.lww.com
The T-cell depleting rabbit polyclonal antibody, anti- human thymocyte globulin (Thymoglobulin), is
currently in use for solid organ transplantation, graft-versus-host disease (GVHD)in hematopoetic
stem-cell transplantation, and ...
Related articles - All 3 versions

Memory T-Cell Predominance Following T-Cell Depletional Therapy Derives from …


A Sener, AL Tang, DL Farber - American Journal of Transplantation, 2009 - pt.wkhealth.com
T-cell depletion reportedly leads to alterations in the T-cell compartment with predominant survival
of memory phenotype CD4 T cells. Here, we asked whether the prevalence of memory T cells
postdepletion results from their ...
Related articles - All 4 versions

Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins …


S Yarkoni, Y Sagiv, A Kaminitz, DL Farkas, … - European journal of …, 2009 - interscience.wiley.com
Pathogenic lymphocytes in the enteric wall of inflammatory bowel disease patients display various
abnormalities, including reduced sensitivity to apoptosis. We evaluated a therapeutic approach to
elimination of cytotoxic cells, ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google